CD70-driven chronic immune activation is protective against atherosclerosis

Journal of Innate Immunity

Volumn 2, Issue 4, 2010, Pages 344-352

  Van Olffen, Ronald W ^a   De Bruin, Alex M ^a   Vos, Mariska ^b   Staniszewska, Anna D ^a   Hamann, Jörg ^a   Van Lier, René A W ^a   De Vries, Carlie J M ^b   Nolte, Martijn A ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Atherosclerosis; CD27; CD70; Mice; Monocyte

Indexed keywords

APOLIPOPROTEIN E; CD70 ANTIGEN; CHOLESTEROL; GAMMA INTERFERON; CD27 ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; B LYMPHOCYTE; CHOLESTEROL BLOOD LEVEL; CHRONIC INFLAMMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; EFFECTOR CELL; FEMALE; IMMUNOSTIMULATION; INNATE IMMUNITY; LYMPHOCYTE COUNT; MONOCYTE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL DIFFERENTIATION; CYTOLOGY; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; METABOLISM; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD27; ANTIGENS, CD70; APOLIPOPROTEINS E; APOPTOSIS; ATHEROSCLEROSIS; B-LYMPHOCYTES; CELL DIFFERENTIATION; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MONOCYTES; PHAGOCYTOSIS; T-LYMPHOCYTES;

EID: 77954042295     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000314772     Document Type: Article

References (27)

1. Becker AE, de Boer OJ, van der Wal AC: The role of inflammation and infection in coronary artery disease. Ann Rev Med 2001; 52: 289-297. (Pubitemid 32195326)
2. Epstein SE, Zhu J, Burnett MS, Zhou YF, Vercellotti G, Hajjar D: Infection and atherosclerosis: potential roles of pathogen burden and molecular mimicry. Arterioscler Thromb Vasc Biol 2000; 20: 1417-1420. (Pubitemid 30353867)
3. Leinonen M and Saikku P: Evidence for infectious agents in cardiovascular disease and atherosclerosis. Lancet Infect Dis 2002; 2: 11-17. (Pubitemid 36109301)
4. Hansson GK, Libby P: The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 2006; 6: 508-519. (Pubitemid 43980523)
5. Nolte MA, van Olffen RW, van Gisbergen KP, van Lier RA: Timing and tuning of CD27-CD70 interactions: the impact of signal strength in setting the balance between adaptive responses and immunopathology. Immunol Rev 2009; 229: 216-231.
6. Hendriks J, Xiao Y, Borst J: CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool. J Exp Med 2003; 198: 1369-1380. (Pubitemid 37392482)
7. Peperzak V, Xiao Y, Veraar EA, Borst J: CD27 sustains survival of CTLs in virus-infected nonlymphoid tissue in mice by inducing autocrine IL-2 production. J Clin Invest 2010; 120: 168-178.
8. Arens R, Tesselaar K, Baars PA, van Schijndel GM, Hendriks J, Pals ST, Krimpenfort P, Borst J, van Oers MH, van Lier RA: Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNgamma-mediated B cell depletion. Immunity 2001; 15: 801-812. (Pubitemid 34008507)
9. Arens R, Schepers K, Nolte MA, van Oosterwijk MF, van Lier RA, Schumacher TN, van Oers MH: Tumor rejection induced by CD70-mediated quantitative and qualitative effects on effector CD8+ T cell formation. J Exp Med 2004; 199: 1595-1605. (Pubitemid 38780414)
10. Tesselaar K, Arens R, van Schijndel GM, Baars PA, van d, V, Borst J, van Oers MH, van Lier RA: Lethal T cell immunodeficiency induced by chronic costimulation via CD27- CD70 interactions. Nat Immunol 2003; 4: 49-54. (Pubitemid 36104708)
11. van Vlijmen BJ, van den Maagdenberg AM, Gijbels MJ, van der Boom H, HogenEsch H, Frants RR, Hofker MH, Havekes LM: Dietinduced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice. J Clin Invest 1994; 93: 1403-1410. (Pubitemid 24116375)
12. Caligiuri G, Nicoletti A, Poirier B, Hansson GK: Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J Clin Invest 2002; 109: 745-753. (Pubitemid 34263151)
13. Major AS, Fazio S, Linton MF: B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice. Arterioscler Thromb Vasc Biol 2002; 22: 1892-1898. (Pubitemid 35315778)
14. Galkina E, Ley K: Immune and inflammatory mechanisms of atherosclerosis. Annu Rev Immunol 2009; 27: 165-197.
15. Geissmann F, Jung S, Littman DR: Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003; 19: 71-82. (Pubitemid 36859902)
16. Swirski FK, Libby P, Aikawa E, Alcaide P, Luscinskas FW, Weissleder R, Pittet MJ: Ly- 6Chi monocytes dominate hypercholesterolemia- associated monocytosis and give rise to macrophages in atheromata. J Clin Invest 2007; 117: 195-205. (Pubitemid 46048466)
17. Tacke F, Alvarez D, Kaplan TJ, Jakubzick C, Spanbroek R, Llodra J, Garin A, Liu J, Mack M, van Rooijen N, Lira SA, Habenicht AJ, Randolph GJ: Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest 2007; 117: 185-194. (Pubitemid 46048465)
18. Boesten LS, Zadelaar AS, van NA, Gijbels MJ, de Winther MP, Havekes LM, van Vlijmen BJ: Tumor necrosis factor-alpha promotes atherosclerotic lesion progression in APOE * 3-Leiden transgenic mice. Cardiovasc Res 2005; 66: 179-185.
19. Ohta H, Wada H, Niwa T, Kirii H, Iwamoto N, Fujii H, Saito K, Sekikawa K, Seishima M: Disruption of tumor necrosis factor-alpha gene diminishes the development of atherosclerosis in ApoE-deficient mice. Atherosclerosis 2005; 180: 11-17. (Pubitemid 40501347)
20. Poot M, Gibson LL, Singer VL: Detection of apoptosis in live cells by MitoTracker red CMXRos and SYTO dye flow cytometry. Cytometry 1997; 27: 358-364. (Pubitemid 27158397)
21. Gautier EL, Jakubzick C, Randolph GJ: Regulation of the migration and survival of monocyte subsets by chemokine receptors and its relevance to atherosclerosis. Arterioscler Thromb Vasc Biol 2009; 29: 1412-1418.
22. Nolte MA, Arens R, van Os R, van Oosterwijk M, Hooibrink B, van Lier RA, van Oers MH: Immune activation modulates hematopoiesis through interactions between CD27 and CD70. Nat Immunol 2005; 6: 412-418. (Pubitemid 41716782)
23. Stoneman V, Braganza D, Figg N, Mercer J, Lang R, Goddard M, Bennett M: Monocyte/ macrophage suppression in CD11b diphtheria toxin receptor transgenic mice differentially affects atherogenesis and established plaques. Circ Res 2007; 100: 884-893. (Pubitemid 46555694)
24. Tabas I: Macrophage death and defective inflammation resolution in atherosclerosis. Nat Rev Immunol 2010; 10: 36-46.
25. Swirski FK, Weissleder R, Pittet MJ: Heterogeneous in vivo behavior of monocyte subsets in atherosclerosis. Arterioscler Thromb Vasc Biol 2009; 29: 1424-1432.
26. Leon ML, Zuckerman SH: Gamma interferon: a central mediator in atherosclerosis. Inflamm Res 2005; 54: 395-411.
27. Canault M, Peiretti F, Poggi M, Mueller C, Kopp F, Bonardo B, Bastelica D, Nicolay A, Alessi MC, Nalbone G: Progression of atherosclerosis in ApoE-deficient mice that express distinct molecular forms of TNF-alpha. J Pathol 2008; 214: 574-583. (Pubitemid 351482272)